How can smaller companies survive in the European generics industry?

PRLog (Press Release) - Mar. 23, 2012 - SMi present their 2012 Generics, Supergenerics and Patent Strategies conference that will present attendees with an in-depth overview into current issues in the generics industry and offer detailed viewpoints from the big players in the market.

This event will be the perfect forum for networking and problem solving with senior industry executives, presenting on their experiences of branded generics, partnerships and patent issues.

Benefits of attending include:

Discuss how successful branded generics and supergenerics value for money and how they actually perform in the market

Evaluate the state of the European markets as well at the emerging markets of the MENA regions.

Hear how some large Pharma companies are making moves into generics production in order to compensate for the lack of upcoming blockbuster drugs.

Gain knowledge of current regulatory issues both from industrial representatives and from the regulatory bodies themselves.

Consider the effects of Asian companies entering the European market

Learn about recent patent litigation and the effect it will have on future trials, as well as recent developments in supplementary patent certificates.

For further information visit http://www.smi-online.co.uk/goto/generic-pharma41.asp
or alternatively contact Lola Ameh on tel 44 0207 827 6722 or email on lameh@smi-online.co.uk

Photo:
http://www.prlog.org/11832320/1